✦ LIBER ✦

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

✍ Scribed by Edgardo Rivera; Christina Meyers; Morris Groves; Vicente Valero; Deborah Francis; Banu Arun; Kristine Broglio; Guosheng Yin; Gabriel N. Hortobagyi; Thomas Buchholz

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 90 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22127

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 trial of whole-brain radiother

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

✍ Philippe A. Cassier; Isabelle Ray-Coquard; Marie-Pierre Sunyach; Laurence Lancry 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

Phase I study of eniluracil and oral 5-f

Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma

✍ Edgardo Rivera; Vicente Valero; Massimo Cristofanilli; Debra K. Frye; Daniel J. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

## Abstract ## PURPOSE The authors conducted a single‐institution Phase I clinical trial to determine the maximum tolerated doses and to define the toxic effects of oral eniluracil and oral 5‐fluorouracil (5‐FU) combined with docetaxel in patients with metastatic breast carcinoma. ## PATIENTS AND

A Phase I/II study of strontium-89 combi

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

✍ Lance C. Pagliaro; Ebrahim S. Delpassand; Dallas Williams; Randall E. Millikan; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the maximum tolerated dose and to evaluate the efficacy of gemcitabine given in combination with strontium‐89 to patients with androgen independent prostate carcinoma. ## METHODS Patients with androgen‐independent pr

Phase I/II study of thalidomide in combi

Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma

✍ Robert J. Amato; Margaret Morgan; Anish Rawat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase II study of capecitabine combined

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

✍ Alan Rodney; Pauline Dieringer; Paul Mathew; Eric Jonasch; Nizar Tannir; Lance C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## Abstract ## BACKGROUND The primary objective of the current study was to evaluate the effectiveness of capecitabine and gemcitabine in the treatment of patients with androgen‐independent prostate cancer (AIPCa) who experienced disease progression after taxane therapy. The secondary objective wa

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i